Index gets a dose of medicine
SHANGHAI'S key stock index rose more than 1 percent yesterday, led by health care companies which anticipate they will benefit from new policies on medical reform that are set to be discussed during China's top legislative and advisory sessions.
The Shanghai Composite Index added 1.33 percent, or 39.6 points, to close at 3,022.18. Turnover rose to 105.6 billion yuan (US$15.6 billion) from 98.2 billion yuan on Tuesday.
The National People's Congress and the Chinese People's Political Consultative Conference will begin their annual sessions in Beijing next week. The medical reform, rising home prices and a widening personal income gap are among topics that will be discussed, according to an online poll conducted by people.cn of the People's Daily, xinhuanet.com of Xinhua news agency and cctv.com of the China Central Television.
The central government has shortlisted 16 cities, including Shanghai, to try out a public hospital reform - vital before reforming the medical sector.
Tianjin Zhongxin Pharmaceutical Group Co surged 3.9 percent to 26.84 yuan, and China National Medicines Corp jumped 3 percent to 28.30 yuan.
"The pharmaceutical sector will stay strong with the medical reform," said He Jiawei, an analyst of S&E Securities Brokerage Co.
The Shanghai Composite Index added 1.33 percent, or 39.6 points, to close at 3,022.18. Turnover rose to 105.6 billion yuan (US$15.6 billion) from 98.2 billion yuan on Tuesday.
The National People's Congress and the Chinese People's Political Consultative Conference will begin their annual sessions in Beijing next week. The medical reform, rising home prices and a widening personal income gap are among topics that will be discussed, according to an online poll conducted by people.cn of the People's Daily, xinhuanet.com of Xinhua news agency and cctv.com of the China Central Television.
The central government has shortlisted 16 cities, including Shanghai, to try out a public hospital reform - vital before reforming the medical sector.
Tianjin Zhongxin Pharmaceutical Group Co surged 3.9 percent to 26.84 yuan, and China National Medicines Corp jumped 3 percent to 28.30 yuan.
"The pharmaceutical sector will stay strong with the medical reform," said He Jiawei, an analyst of S&E Securities Brokerage Co.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.